Interpace Biosciences Stock Shares Owned By Insiders
Interpace Biosciences fundamentals help investors to digest information that contributes to Interpace Biosciences' financial success or failures. It also enables traders to predict the movement of Interpace OTC Stock. The fundamental analysis module provides a way to measure Interpace Biosciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Interpace Biosciences otc stock.
Interpace |
Interpace Biosciences OTC Stock Shares Owned By Insiders Analysis
Interpace Biosciences' Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
More About Shares Owned By Insiders | All Equity Analysis
Insiders Shares | = | Executives Shares | + | Employees |
Current Interpace Biosciences Shares Owned By Insiders | 28.12 % |
Most of Interpace Biosciences' fundamental indicators, such as Shares Owned By Insiders, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Interpace Biosciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
CompetitionBased on the latest financial disclosure, 28.116% of Interpace Biosciences are shares owned by insiders. This is 85.22% higher than that of the Health Care Providers & Services sector and 82.81% higher than that of the Health Care industry. The shares owned by insiders for all United States stocks is 178.65% lower than that of the firm.
Interpace Shares Owned By Insiders Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Interpace Biosciences' direct or indirect competition against its Shares Owned By Insiders to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Interpace Biosciences could also be used in its relative valuation, which is a method of valuing Interpace Biosciences by comparing valuation metrics of similar companies.Interpace Biosciences is currently under evaluation in shares owned by insiders category among its peers.
Interpace Fundamentals
Return On Equity | -2.85 | ||||
Return On Asset | -0.26 | ||||
Profit Margin | (0.59) % | ||||
Operating Margin | (0.28) % | ||||
Current Valuation | 11.72 M | ||||
Shares Outstanding | 4.27 M | ||||
Shares Owned By Insiders | 28.12 % | ||||
Number Of Shares Shorted | 47.35 K | ||||
Price To Earning | (1.07) X | ||||
Price To Book | 10.04 X | ||||
Price To Sales | 0.10 X | ||||
Revenue | 41.31 M | ||||
Gross Profit | 17.95 M | ||||
EBITDA | (9.12 M) | ||||
Net Income | (14.94 M) | ||||
Cash And Equivalents | 1.86 M | ||||
Cash Per Share | 0.44 X | ||||
Total Debt | 9.44 M | ||||
Debt To Equity | 6.55 % | ||||
Current Ratio | 0.61 X | ||||
Book Value Per Share | (14.51) X | ||||
Cash Flow From Operations | (8.72 M) | ||||
Short Ratio | 0.19 X | ||||
Earnings Per Share | (3.12) X | ||||
Target Price | 11.0 | ||||
Number Of Employees | 147 | ||||
Beta | 0.82 | ||||
Market Capitalization | 5.16 M | ||||
Total Asset | 38.43 M | ||||
Retained Earnings | (172.59 M) | ||||
Working Capital | (4.21 M) | ||||
Current Asset | 19.16 M | ||||
Current Liabilities | 23.37 M | ||||
Z Score | -4.6 | ||||
Net Asset | 38.43 M |
Currently Active Assets on Macroaxis
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in interest. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Consideration for investing in Interpace OTC Stock
If you are still planning to invest in Interpace Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Interpace Biosciences' history and understand the potential risks before investing.
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |